drugset / Trial / NCT02551172
Evaluating the Efficacy and Safety of HCP1105 in Combined Hyperlipidemic Patients With High Risk for CHD
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate the efficacy and safety after administration of HCP1105 in hyperlipidemic patients with high risk for CHD.
Timeline
- Start
- 2014-10
- Primary completion
- 2016-01
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Omega-3-acids ethyl esters | Unknown | — | — |
| Subject | Rosuvastatin | Small molecule | 20 mg | — |